Avner Thaler

2.8k total citations
71 papers, 1.3k citations indexed

About

Avner Thaler is a scholar working on Neurology, Physiology and Cognitive Neuroscience. According to data from OpenAlex, Avner Thaler has authored 71 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Neurology, 25 papers in Physiology and 15 papers in Cognitive Neuroscience. Recurrent topics in Avner Thaler's work include Parkinson's Disease Mechanisms and Treatments (52 papers), Lysosomal Storage Disorders Research (20 papers) and Neurological disorders and treatments (18 papers). Avner Thaler is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (52 papers), Lysosomal Storage Disorders Research (20 papers) and Neurological disorders and treatments (18 papers). Avner Thaler collaborates with scholars based in Israel, United States and Netherlands. Avner Thaler's co-authors include Nir Giladi, Anat Mirelman, Avi Orr‐Urtreger, Tanya Gurevich, Anat Bar‐Shira, Karen Marder, Susan Bressman, Mali Gana‐Weisz, Tamara Shiner and Jeffrey M. Hausdorff and has published in prestigious journals such as PLoS ONE, NeuroImage and Brain.

In The Last Decade

Avner Thaler

70 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Avner Thaler Israel 21 973 430 239 215 189 71 1.3k
Sophie Winder‐Rhodes United Kingdom 12 1.0k 1.0× 537 1.2× 339 1.4× 178 0.8× 315 1.7× 13 1.5k
Stefanie Lerche Germany 19 634 0.7× 279 0.6× 87 0.4× 106 0.5× 170 0.9× 37 1.1k
Chelsea Caspell‐Garcia United States 22 1.3k 1.4× 290 0.7× 329 1.4× 197 0.9× 272 1.4× 30 1.5k
Berta C. Leis United States 15 727 0.7× 269 0.6× 126 0.5× 250 1.2× 238 1.3× 19 966
Maria Antonietta Volonté Italy 22 823 0.8× 152 0.4× 298 1.2× 270 1.3× 274 1.4× 56 1.3k
Karen Frei United States 18 587 0.6× 352 0.8× 92 0.4× 83 0.4× 220 1.2× 38 1.3k
Inga Liepelt Germany 17 955 1.0× 250 0.6× 161 0.7× 119 0.6× 339 1.8× 23 1.2k
Alexander Pantelyat United States 18 612 0.6× 172 0.4× 147 0.6× 104 0.5× 214 1.1× 75 970
Laura Vacca Italy 21 1.6k 1.6× 158 0.4× 181 0.8× 316 1.5× 468 2.5× 58 1.8k
Yongsheng Yuan China 20 693 0.7× 103 0.2× 315 1.3× 151 0.7× 197 1.0× 71 1.1k

Countries citing papers authored by Avner Thaler

Since Specialization
Citations

This map shows the geographic impact of Avner Thaler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avner Thaler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avner Thaler more than expected).

Fields of papers citing papers by Avner Thaler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avner Thaler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avner Thaler. The network helps show where Avner Thaler may publish in the future.

Co-authorship network of co-authors of Avner Thaler

This figure shows the co-authorship network connecting the top 25 collaborators of Avner Thaler. A scholar is included among the top collaborators of Avner Thaler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Avner Thaler. Avner Thaler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Droby, Amgad, Dikla Atias, Kyle Fraser, et al.. (2025). Radiological markers of CSF α-synuclein aggregation in Parkinson’s disease patients. npj Parkinson s Disease. 11(1). 7–7. 4 indexed citations
2.
Thaler, Avner, Lior Greenbaum, H. Shabtai, et al.. (2024). Levodopa-carbidopa intestinal gel for advanced Parkinson's disease: Impact of LRRK2 and GBA1 mutations. Parkinsonism & Related Disorders. 127. 107115–107115. 1 indexed citations
3.
Tauman, Riva, et al.. (2023). Overnight Distribution of REM Sleep Features in People with Parkinson’s Disease (PD) and Non-PD Controls. Journal of Parkinson s Disease. 13(7). 1213–1223. 3 indexed citations
4.
Mirelman, Anat, Eran Gazit, Alice Nieuwboer, et al.. (2023). Digital Mobility Measures: A Window into Real‐World Severity and Progression of Parkinson's Disease. Movement Disorders. 39(2). 328–338. 14 indexed citations
5.
Goldstein, Orly, Mali Gana‐Weisz, Sandro Banfi, et al.. (2023). Novel variants in genes related to vesicle-mediated-transport modify Parkinson's disease risk. Molecular Genetics and Metabolism. 139(2). 107608–107608. 5 indexed citations
6.
Taymans, Jean‐Marc, Warren D. Hirst, Adamantios Mamais, et al.. (2023). Perspective on the current state of the LRRK2 field. npj Parkinson s Disease. 9(1). 104–104. 56 indexed citations
7.
Bregman, Noa, Tamara Shiner, Gitit Kavé, et al.. (2023). The natural history study of preclinical genetic Creutzfeldt-Jakob Disease (CJD): a prospective longitudinal study protocol. BMC Neurology. 23(1). 151–151. 3 indexed citations
8.
Bashat, Dafna Ben, Avner Thaler, Einat Even‐Sapir, et al.. (2022). Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease. npj Parkinson s Disease. 8(1). 139–139. 16 indexed citations
9.
Kizony, Rachel, Jesse M. Cedarbaum, Noa Bregman, et al.. (2021). Quantitative digital clock drawing test as a sensitive tool to detect subtle cognitive impairments in early stage Parkinson's disease. Parkinsonism & Related Disorders. 90. 84–89. 8 indexed citations
10.
Thaler, Avner, Nir Giladi, Tanya Gurevich, et al.. (2021). Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory Markers. Journal of Parkinson s Disease. 11(3). 1285–1296. 20 indexed citations
11.
Thaler, Avner, Nir Giladi, Tanya Gurevich, et al.. (2021). Biochemical markers for severity and risk in GBA and LRRK2 Parkinson’s disease. Journal of Neurology. 268(4). 1517–1525. 10 indexed citations
12.
Mirelman, Anat, Inbar Hillel, Lynn Rochester, et al.. (2020). Tossing and Turning in Bed: Nocturnal Movements in Parkinson's Disease. Movement Disorders. 35(6). 959–968. 40 indexed citations
13.
Droby, Amgad, Tanya Gurevich, Meir Kestenbaum, et al.. (2020). Low cerebrospinal fluid volume and the risk for post-lumbar puncture headaches. Journal of the Neurological Sciences. 417. 117059–117059. 4 indexed citations
14.
Thaler, Avner. (2018). Structural and Functional MRI in Familial Parkinson's Disease. International review of neurobiology. 142. 261–287. 5 indexed citations
15.
Thaler, Avner, Noa Bregman, Tanya Gurevich, et al.. (2018). Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene. Parkinsonism & Related Disorders. 55. 45–49. 88 indexed citations
16.
Saunders‐Pullman, Rachel, Anat Mirelman, Roy N. Alcalay, et al.. (2018). Progression in the LRRK2-Associated Parkinson Disease Population. JAMA Neurology. 75(3). 312–312. 94 indexed citations
17.
Thaler, Avner, Efrat Kliper, Talia Herman, et al.. (2018). Cerebral Imaging Markers of GBA and LRRK2 Related Parkinson’s Disease and Their First-Degree Unaffected Relatives. Brain Topography. 31(6). 1029–1036. 21 indexed citations
18.
Thaler, Avner, Tanya Gurevich, Anat Bar Shira, et al.. (2016). A “dose” effect of mutations in the GBA gene on Parkinson's disease phenotype. Parkinsonism & Related Disorders. 36. 47–51. 80 indexed citations
19.
Nuenen, Bart F.L. van, Rick C. Helmich, Murielle Ferraye, et al.. (2012). Cerebral pathological and compensatory mechanisms in the premotor phase of leucine-rich repeat kinase 2 parkinsonism. Brain. 135(12). 3687–3698. 25 indexed citations
20.
Sadeh, Boaz, David Pitcher, Talia Brandman, et al.. (2011). Stimulation of Category-Selective Brain Areas Modulates ERP to Their Preferred Categories. Current Biology. 21(22). 1894–1899. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sophie Winder‐Rhodes Breakdown of academic impact, for papers by Stefanie Lerche Breakdown of academic impact, for papers by Chelsea Caspell‐Garcia Breakdown of academic impact, for papers by Berta C. Leis Breakdown of academic impact, for papers by Maria Antonietta Volonté Breakdown of academic impact, for papers by Karen Frei Breakdown of academic impact, for papers by Inga Liepelt Breakdown of academic impact, for papers by Alexander Pantelyat Breakdown of academic impact, for papers by Laura Vacca Breakdown of academic impact, for papers by Yongsheng Yuan
Rankless by CCL
2026